Exilis Pharma Private Limited
About Exilis Pharma Private Limited
Data last updated:
Exilis Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 December 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U52100MH2022PTC396439. Its GSTIN is 23AAHCE4009P1ZJ (Madhya Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajesh Kumar Baranwal and Avesh Kumar Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 104 Floor 1 Bussa Industrial Estate Shankarrao Naram Marg Nrpeninsula Copark, Mumbai, Maharashtra, India – 400013.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address104 Floor 1 Bussa Industrial Estate Shankarrao Naram Marg Nrpeninsula Copark, Mumbai, Maharashtra, India – 400013
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Exilis Pharma Private Limited FY 2025 filings available
Financial Statement Summary of Exilis Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Exilis Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Exilis Pharma are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Exilis Pharma Private Limited
Exilis Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Kumar Baranwal Also directs: Nicolan Healthcare Private Limited, Rakesh Medical Agencies Private Limited, Medihub Enterprises Private Limited and 4 more | Director | 30 Dec 2022 | 3 Years 9 Months | Current |
| Avesh Kumar Jain | Director | 30 Dec 2022 | 3 Years 9 Months | Current |
Charges & Borrowings of Exilis Pharma Private Limited
Exilis Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Exilis Pharma Private Limited
Employment history and EPFO contributions of people linked to Exilis Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Exilis Pharma Private Limited
Exilis Pharma Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Avesh Kumar Jain was appointed as Director on 30 Dec 2022.
Credit Ratings, Litigation & Regulatory Alerts for Exilis Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Exilis Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Exilis Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Exilis Pharma Private Limited
Exilis Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAHCE4009P1ZJ | Madhya Pradesh | Active | 29 May 2024 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Exilis Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Exilis Pharma Private Limited
Exilis Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 December 2022 (4+ years old) and is registered under CIN U52100MH2022PTC396439.
Exilis Pharma has 2 current directors:
- Rajesh Kumar Baranwal - Director
- Avesh Kumar Jain - Director
The GSTIN of Exilis Pharma is 23AAHCE4009P1ZJ, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Exilis Pharma is U52100MH2022PTC396439. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Exilis Pharma was incorporated on 30 December 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
Avesh Kumar Jain was appointed as Director on 30 Dec 2022. Rajesh Kumar Baranwal was appointed as Director on 30 Dec 2022.
The registered office of Exilis Pharma is at 104 Floor 1 Bussa Industrial Estate Shankarrao Naram Marg Nrpeninsula Copark, Mumbai, Maharashtra, India – 400013.
Exilis Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
Exilis Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
No. Exilis Pharma is not listed on any stock exchange. It is an unlisted company.